Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FOLFIRI in Second or Third Line Metastatic Colorectal Cancer
NCT00075595Phase 2Unknown
- Sponsor
- GERCOR
- Start
- Jun 2002
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of fluorouracil, folinic acid, irinotecan in colorectal cancer (CRC), sponsored by GERCOR. Status: unknown.
02
Drugs
fluorouracilfolinic acidirinotecan
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00075595.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00075595.